SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-035783
Filing Date
2021-05-25
Accepted
2021-05-25 18:59:45
Documents
1
Period of Report
2021-05-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4014
  Complete submission text file 0001209191-21-035783.txt   5405
Mailing Address C/O NGM BIOPHARMACEUTICALS, INC. 333 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
JONKER JEFFREY DAVID (Reporting) CIK: 0001589394 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39512 | Film No.: 21962233

Mailing Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121
Business Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121 858-369-7800
Metacrine, Inc. (Issuer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations